{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:41:41Z","timestamp":1786639301890,"version":"build-2736575974"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"DOI":"10.7759\/cureus.114483","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:15:46Z","timestamp":1786637746000},"source":"Crossref","is-referenced-by-count":0,"title":["Left Ventricular Recovery Following Bromocriptine Initiation at Different Stages of Peripartum Cardiomyopathy: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Tomohide","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunjiro","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek V","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018, 39:3165-241. 10.1093\/eurheartj\/ehy340","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner D","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al.. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128:589-600. 10.1016\/j.cell.2006.12.036","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten IS","year":"2012","unstructured":"Patten IS, Rana S, Shahul S, et al.. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012, 485:333-8. 10.1038\/nature11040","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study","volume":"121","author":"Sliwa K","year":"2010","unstructured":"Sliwa K, Blauwet L, Tibazarwa K, et al.. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010, 121:1465-73. 10.1161\/CIRCULATIONAHA.109.901496","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner D","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, et al.. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017, 38:2671-9. 10.1093\/eurheartj\/ehx355","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs J","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P, et al.. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019, 21:827-43. 10.1002\/ejhf.1493","journal-title":"Eur J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf193","article-title":"2025 ESC Guidelines for the management of cardiovascular disease and pregnancy","volume":"46","author":"De Backer J","year":"2025","unstructured":"De Backer J, Haugaa KH, Hasselberg NE, et al.. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025, 46:4462-568. 10.1093\/eurheartj\/ehaf193","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523731-left-ventricular-recovery-following-bromocriptine-initiation-at-different-stages-of-peripartum-cardiomyopathy-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:15:46Z","timestamp":1786637746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523731-left-ventricular-recovery-following-bromocriptine-initiation-at-different-stages-of-peripartum-cardiomyopathy-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.114483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}